Today, Rylie's focus with her team is

to supply quality, whole-plant botanical oil to all generations looking for holistic relief of various debilitating health conditions.

Rylie's Story

In 2013, at the age of 7, Rylie was diagnosed with aggressive bone tumors that disintegrated her facial bones. Her mother, Janie, learned about the efficacy of cannabinoids and decided to give it to Rylie hoping it might help minimize her bone tumors and prevent recurrence. With the help of whole plant botanical oil, Rylie defied everyone's expectations. Rylie's smile returned.

Today, Rylie's focus with her team is to supply quality whole-plant botanical oil to all generations looking for holistic relief to various debilitating health conditions. Research is a big part of Rylie's Sunshine's goal since it is one of the dilemmas Rylie's family has noticed can hold back patient care and legislation, besides lack of quality and access. Rylie has chosen specific targets that her team agrees are lacking in research and need to be pushed to the forefront.

Our Advisory Team

Sharlene Mavor.jpg

Sharlene Mavor

Board Advisor

Sharlene is a Medical Scientist (BAppSc -Medical Laboratory Science) and director of Medical Cannabis Research Australia who has been researching how Medical Cannabis may treat an ever-increasing array of disorders. Her university background in diagnostic pathology gives her the knowledge to understand disease processes in the human body.


She’s traveled to the US, Canada, Israel, Colombia and Chile to learn firsthand from the leading researchers in this new field of cannabinoid science. She’s passionate about sharing this knowledge by educating others under the banner of her charity Medical Cannabis Research Australia.


She is committed to advocating for use and access to medical cannabis for patients in Australia as well as promoting more research to give clinicians the evidence they require to pursue this treatment for their patients, both in Australia and in the rest of the world.

Paul Mavor

Board Advisor

Paul is a pharmacist who has been researching the potential for medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada, and Israel. You can read more about Health House here. 

Dr. Reggie Gaudino

VP Research & Development

Dr. Reggie Gaudino oversees the cannabis genetics and scientific research division for Front Range Biosciences (FRB). Formerly the President at Steep Hill, the acquisition of Reggie and his team has significantly advanced FRB’s breeding program, resulting in additional unique and advantaged cannabis and hemp varieties.


Previously, Dr. Gaudino has served as a genetics researcher with 18 years of intellectual property experience in patent writing, management, and prosecution in fields as diverse as software and telecommunications to biotechnology and molecular genetics. Research from Dr. Gaudino has been peer-reviewed and published, leading to important new discoveries in the cannabis industry.


As an internationally recognized leader in the field of cannabis genetics, Dr. Gaudino has served as a patent agent at Sequenom, Inc., managed IP-based acquisitions for the Vortice Research Group, worked at four law firms focused on biotechnology, and has served as an advisor to multiple portfolio investment companies. Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the State University of New York at Buffalo and conducted four years of post-doctoral research at Washington University in St. Louis.

Dr. Mark Rabe

Board Advisor

Dr. Mark L. Rabe is an integrative medicine specialist and leading figure in the evolving field of cannabinoid medicine. Dr. Rabe earned his medical degree at Northwestern University Medical School.  He is the Chief Executive Officer of Rabe Medical Solutions, LLC, a company that offers consulting and education to individuals seeking to attain optimal health and manage chronic medical conditions using natural methods. Dr. Rabe is also Director of Cannabinoid Program Development at PharmaCyte Biotech.

Previously, Dr. Rabe served as Chief Medical Officer of California’s largest network of physician-owned integrative care centers. There he hired and trained medical personnel, organized public educational symposia and media outreach, conducted research and supervised the recommendation of natural treatment options to over 100,000 patients in 20 medical clinics across California. Dr. Rabe graduated summa cum laude with a degree in biochemistry from Benedictine University, where he performed research in the area of cancer drug synthesis.


Based on the East Coast, USA

  • Facebook
  • Twitter
  • Instagram